Alpha 2.0
Login Register
» Authors » Thomas Villeneuve

Thomas Villeneuve

Explore the profile of Thomas Villeneuve including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 20
Followers 0
Related Specialties
Pulmonary Medicine
Allergy & Immunology
General Medicine
Top 10 Co-Authors
Nicolas Guibert
Gregoire Prevot
Valentin Heluain
Benjamin Renaud-Picard
Gavin Plat
Jean-Francois Mornex
Antoine Roux
Xavier Demant
Jerome Le Pavec
Benjamin Coiffard
Published In
Respir Med Res
ERJ Open Res
Eur Respir J
Allergy
Front Med (Lausanne)
Affiliations
Soon will be listed here.
Recent Articles
1.
"Lung tensioning device" for emphysema: The comeback of the coil
Guibert N, Villeneuve T, Edme J, Mazieres J, Plat G, Heluain V
Respir Med Res . 2025 Mar; 87:101163. PMID: 40024153
No abstract available.
2.
Forced vital capacity reduction severity in pulmonary fibrosis and post-lung transplantation outcomes
Leveque M, Bermudez J, Nieves A, Daviet F, Roux A, Demant X, et al.
Respir Med Res . 2025 Feb; 87:101158. PMID: 39946979
Background: The ISHLT guidelines recommend early referral to a lung transplantation (LTx) center for patients with interstitial lung disease (ILD) due to the unpredictable course. To our knowledge, no study...
3.
Efficacy of convalescent plasma for the treatment of COVID-19 in lung transplant recipients: A multicenter French study
Chaudhry A, Gallais F, Falcoz P, De Verdiere S, Villeneuve T, Horeau D, et al.
Respir Med Res . 2024 Dec; 87:101145. PMID: 39689664
Introduction: Lung transplant (LT) recipients are at greater risk of complications from COVID-19. Treatment options are limited partly due to interactions with immunosuppressive agents. Convalescent plasma (CP) is a potential...
4.
Sarcoid-like reaction related to ALK-ROS inhibitors in lung cancer patients
Morin C, Villeneuve T, Norkowski E, Rosencher L, Cadranel J, Mazieres J
Respir Med Res . 2024 Sep; 86:101138. PMID: 39288551
No abstract available.
5.
Description and first insights on a large genomic biobank of lung transplantation
Brocard S, Morin M, Dos Santos Brito Silva N, Renaud-Picard B, Coiffard B, Demant X, et al.
Eur J Hum Genet . 2024 Aug; 33(3):304-311. PMID: 39164465
The main limitation to long-term lung transplant (LT) survival is chronic lung allograft dysfunction (CLAD), which leads to irreversible lung damage and significant mortality. Individual factors can impact CLAD, but...
6.
Clinical and biological characteristics associated with bronchial or pulmonary abnormalities on chest CT imaging in patients with systemic mastocytosis
Valliere R, Livideanu C, Villeneuve T, Prevot G, Reber L, Guilleminault L
Clin Transl Allergy . 2024 Aug; 14(8):e12387. PMID: 39107959
No abstract available.
7.
Domestic Mixed-Dust Pneumoconiosis
Villeneuve T, Foulquier S, Nguyen A, Vigier A, Prevot G
Am J Respir Crit Care Med . 2024 Jul; 210(10):1267-1268. PMID: 39041894
No abstract available.
8.
Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
Villeneuve T, Guilleminault L, Guibert N
Arch Bronconeumol . 2024 May; 60(9):600-601. PMID: 38755056
No abstract available.
9.
Combination of electromagnetic navigation and probe-based LASER endomicroscopy to guide non-solid nodules sampling: Results from the CELTICS 2 study
Kalifa J, Plat G, Brindel A, Heluain V, Brouchet L, Rouch A, et al.
Respir Med Res . 2024 Apr; 85:101092. PMID: 38657300
No abstract available.
10.
Blood MMP-9 measured at 2 years after lung transplantation as a prognostic biomarker of chronic lung allograft dysfunction
Tissot A, Durand E, Goronflot T, Coiffard B, Renaud-Picard B, Roux A, et al.
Respir Res . 2024 Feb; 25(1):88. PMID: 38336710
Background: Long-term outcomes of lung transplantation (LTx) remain hampered by chronic lung allograft dysfunction (CLAD). Matrix metalloproteinase 9 (MMP-9) is a secretory endopeptidase identified as a key mediator in fibrosis...